Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Huber

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Seminars in Cancer Biology|March 8, 2017
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulationVeronica Huber, Chiara Camisaschi, Angela Berzi, et al.
Cancer Research|September 20, 2006
Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytesRoberta Valenti, Veronica Huber, Paola Filipazzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2022
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer ScreeningOrazio Fortunato, Veronica Huber, Miriam Segale, et al.
Immunological Reviews|November 26, 2002
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interactionLicia Rivoltini, Matteo Carrabba, Veronica Huber, et al.
Expert Opinion on Biological Therapy|June 7, 2005
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Licia Rivoltini, Paola Canese, Veronica Huber, et al.
Frontiers in Immunology|August 15, 2020
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer ImmunotherapyElena Daveri, Elisabetta Vergani, Eriomina Shahaj, et al.
Blood|January 17, 2004
IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cellsCristina Tecchio, Veronica Huber, Patrizia Scapini, et al.
Cancer Research|May 4, 2005
Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96Lorenzo Pilla, Paola Squarcina, Jorgelina Coppa, et al.
Iscience|January 22, 2025
Reprogramming the melanoma and immunosuppressive myeloid cells with esomeprazole-loaded PLGA nanoparticlesNicola Cerioli, Wissem Bououdina, Alessandro Mereu, et al.
Journal of Clinical Medicine|April 2, 2020
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?Alessia Mennitto, Veronica Huber, Raffaele Ratta, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Seminars in Cancer Biology|March 8, 2017
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulationVeronica Huber, Chiara Camisaschi, Angela Berzi, et al.
Cancer Research|September 20, 2006
Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytesRoberta Valenti, Veronica Huber, Paola Filipazzi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2022
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer ScreeningOrazio Fortunato, Veronica Huber, Miriam Segale, et al.
Immunological Reviews|November 26, 2002
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interactionLicia Rivoltini, Matteo Carrabba, Veronica Huber, et al.
Expert Opinion on Biological Therapy|June 7, 2005
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Licia Rivoltini, Paola Canese, Veronica Huber, et al.
Frontiers in Immunology|August 15, 2020
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer ImmunotherapyElena Daveri, Elisabetta Vergani, Eriomina Shahaj, et al.
Blood|January 17, 2004
IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cellsCristina Tecchio, Veronica Huber, Patrizia Scapini, et al.
Cancer Research|May 4, 2005
Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96Lorenzo Pilla, Paola Squarcina, Jorgelina Coppa, et al.
Iscience|January 22, 2025
Reprogramming the melanoma and immunosuppressive myeloid cells with esomeprazole-loaded PLGA nanoparticlesNicola Cerioli, Wissem Bououdina, Alessandro Mereu, et al.
Journal of Clinical Medicine|April 2, 2020
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?Alessia Mennitto, Veronica Huber, Raffaele Ratta, et al.
Pageof 7